The Motley Fool has been providing investing insights and personal finance to millions of people for over 25 years. Learn how we make the world Smarter, Happier ...

Alex Carchidi is a contributing Motley Fool healthcare and cryptocurrency analyst covering biotech, pharma, cannabis, and digital asset companies. Previously, Alex was a bench scientist and science ...

This agribusiness leader, known for grain trading and ethanol production, reported a notable insider sale amid a year of ...

While companies like Amazon ( AMZN 1.40%) and Alphabet ( GOOG +0.05%) ( GOOGL 0.04%) are both major Nvidia customers, they ...

From small-cap volatility to mega-cap stability, these two ETFs highlight the trade-offs between diversification, risk, and ...

Automotive and Industrial Revenue -- Combined 44% of product revenue, a two-percentage-point increase over the prior quarter, ...

Q2 2026 Guidance -- Revenue $205 million; gross margin ~43%; operating expenses ~$59 million; adjusted EBITDA ~$34 million; ...

A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct ...

Amazon stock investors are not convinced the capital investments are worthwhile. Amazon ( AMZN 1.39%) is forecasting it will ...

Thursday, May 7, 2026 at 5 p.m. ET. CALL PARTICIPANTS. Chief Executive Officer — Drew Houston; Chief Financial Officer — Ross ...

Ipratropium Bromide Inhalation (AMP007) -- Approved by FDA and launched in April; currently the sole generic ipratropium ...